Search
News
Preclinical Study Shows Targeted Drug Strengthens the Power of CAR T-Cell Therapy in Two Pediatric Leukemias
… Therapy in Two Pediatric Leukemias Roswell Park’s Dr. Lisa Niswander presents research results at American Society of … KMT2A-rearranged acute lymphoblastic leukemia (ALL). Lisa Niswander, MD, PhD , Assistant Professor of Oncology in the … toxicities and improve long-term remission,” says Dr. Niswander. “Our preclinical studies take a two-pronged …
Roswell Park at American Society of Hematology 2024
… Transplant & Cellular Therapy Department of Medicine Lisa Niswander, MD, PhD Assistant Professor of Oncology Department … Lymphocytic Leukemia with Venetoclax Treatment Dr. Lisa Niswander presenting 370 - Gilteritinib Augments Preclinical …
Department of Immunology Faculty
… Oncology Shared Resource Department of Immunology Lisa Niswander, MD, PhD Assistant Professor of Oncology Kazuaki …
Research
Translational Research Groups
… Fenstermaker, MD Pediatric Nataliya Buxbaum, MD Lisa Niswander, MD, PhD Soft Tissue Melanoma (STM) Joyce Ohm, PhD … Fenstermaker, MD Pediatric Nataliya Buxbaum, MD Lisa Niswander, MD, PhD Soft Tissue Melanoma (STM) Joyce Ohm, PhD …
Page with Layout
CAR T-Cell Therapy
News
Roswell Park Experts to Showcase Groundbreaking Hematology Research at 66th ASH Annual Meeting
… is senior author. On Saturday, Dec. 7, at 4:45 p.m., Lisa Niswander, MD, PhD , will present abstract 370, Gliteritinib … is senior author. On Saturday, Dec. 7, at 4:45 p.m., Lisa Niswander, MD, PhD , will present abstract 370, Gliteritinib …